Notice Pursuant to the National Cooperative Research and Production Act of 1993-The Integrated Photonics Institute for Manufacturing Innovation Operating Under the Name of the American Institute for Manufacturing Integrated Photonics, 2178 [2022-00581]
Download as PDF
<![CDATA[
2178
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
The last notification was filed with
the Department on October 5, 2021. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on October 22, 2021 (86 FR 58690).
Register pursuant to Section 6(b) of the
Act on October 5, 2021 (86 FR 55001).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2022–00581 Filed 1–12–22; 8:45 am]
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
BILLING CODE 4410–11–P
[FR Doc. 2022–00613 Filed 1–12–22; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–11–P
Antitrust Division
DEPARTMENT OF JUSTICE
Antitrust Division
jspears on DSK121TN23PROD with NOTICES1
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—The Integrated Photonics
Institute for Manufacturing Innovation
Operating Under the Name of the
American Institute for Manufacturing
Integrated Photonics
Notice is hereby given that, on
November 23, 2021, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), the
Integrated Photonics Institute for
Manufacturing Innovation operating
under the name of the American
Institute for Manufacturing Integrated
Photonics (‘‘AIM Photonics’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Regents of the University of Minnesota,
Minneapolis, MN; Buhler Inc. Leybold
Optics, Cary, NC; and Spark Photonics
Design, Inc., Waltham, MA, have been
added as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and AIM
Photonics intends to file additional
written notifications disclosing all
changes in membership.
On June 16, 2016, AIM Photonics
filed its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on July 25, 2016 (81 FR
48450).
The last notification was filed with
the Department on August 19, 2021. A
notice was published in the Federal
VerDate Sep<11>2014
18:18 Jan 12, 2022
Jkt 256001
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on
November 29, 2021, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Medical Technology Enterprise
Consortium (‘‘MTEC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Integration Innovation Inc.,
Huntsville, AL; HackerOne, San
Francisco, CA; Advanced Materials and
Devices, Inc., Reno, NV; Cimarron
Software Services Inc.,Houston, TX;
Delta Chase LLC., West Chester, OH;
Virginia Commonwealth University,
Richmond, VA; H&H Medical
Corporation, Williamsburg, VA;
Spectrohm Inc. Tysons Corner, VA;
Rubix LS, Lawrence, MA; University of
Florida, Gainesville, FL; Phagelux
(Canada) Inc., Montre´al, CAN; Next
Science, LLC., Jacksonville, FL;
BlackBox Biometrics, Inc. (B3)
Rochester, NY; VitaCyte LLC.,
Indianapolis, IN; Synedgen, Inc.,
Claremont, CA; KeriCure Medical,
Wesley Chapel, FL; Kurve Technology
Inc., Lynnwood,WA; SweetBio, Inc.
Memphis, TN; DLH Silver Spring, MD;
Novel Technologies Holdings Limited,
Manchester, NH; KERECIS Limited,
Isafjordur, ISL; NanoOxygenic LLC.,
Dallas, PA; Georgia State University
Research Foundation, Inc. Atlanta, GA;
Retia Medical LLC., Valhalla, NY;
AivoCode Inc. La Jolla, CA; Medical
Informatics Corp., Houston, TX;
Technatomy Corporation Fairfax, VA;
Terida LLC. Pinehurst, NC; Appili
Therapeutics, Inc., Halifax, CAN;
Continuous Precision Medicine(CPM)
Research, Triangle Park, NC; Overseas
Strategic Consulting, Ltd, Philadelphia,
PA; Vizbii Technologies, Inc.,
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Charleston, SC; Anthem Engineering
LLC., Elkridge,MD; Perfusion Medical,
LLC. Reston, VA; New York University,
New York, NY; Catharsis Productions,
Chicago,IL; University of New
Hampshire Durham, NH; Aldyn, Boston,
MA; GEN–AVIV LLC., North Miami
Beach, FL; NeuroFlow, Inc.,
Philadelphia, PA; Advancement
Strategy, LLC., Columbia, MD.; Belle
Artificial Intelligence Corporation,
Cambridge, MA; Diagnoss Inc, Pomona,
CA; San Diego State University, San
Diego, CA; Dovel Technologies,
McLean, VA; ASSURSEC, LLC.,
LEESBURG, VA; Rhode Island Hospital,
Providence, RI; University of
Connecticut, Storrs, CT; Alertgy, Inc.
MELBOURNE, FL; Boston University,
Boston, MA; MBio Diagnostics, Inc. dba
LightDeck Diagnostics, Boulder, CO;
Pacific Institute for Research and
Evaluation, Beltsville, MD; Tactical
Medical Solutions, LLC., Anderson, SC;
ViiNetwork, Inc., ViiMed, Washington,
DC; Renaissance Biotech, LLC., Malibu,
CA; Bio1 Systems, Inc., San Carlos, CA;
DataRobot, Boston, MA; Knowesis Inc.,
Fairfax, VA; MassBiologics of the
UMMS, Boston, MA; SOLUTE Inc., San
Diego, CA; Aktiv Pharma Group,
Broomfield, CO; Bettermeant, Inc.,
Berkeley, CA; SanMelix Laboratories,
Inc., Hollywood, FL; Viscus Biologics
LLC., Cleveland, OH; Guidehouse Inc.
Falls Church, VA; Movement Rx
Physical Therapy, P.C., San Diego, CA;
Promethean LifeSciences, Inc.,
Pittsburgh, PA; Tygrus LLC., Troy, MI;
MiMedx Group, Inc., Marietta, GA;
Neomatrix Therapeutics, Inc., Stony
Brook, NY; PuraLab LLC., Wilsonville,
OR; InterSystems Corporation,
Cambridge, MA; Full Spectrum Omega,
Inc., Los Angeles, CA; Rockland
Technimed Limited, Mahwah, NJ;
MediWound, Ltd., Yavne, ISR;
Primmune Therapeutics, Inc., San
Diego, CA; Western Michigan University
Homer Stryker M.D. School of
Medicine, Kalamazoo, MI; Emmes
Company LLC., Rockville MD; Canvas
Incorporated, Huntsville, AL; Purgo
Scientific, LLC., South Jordan, UT;
Dascena, Houston, TX; Through The
Cords LLC., Salt Lake City, UT; Armed
Forces Services Corporation dba
Magellan Federal, Arlington, VA;
Immuron Limited, Victoria, AUS;
Terumo BCT Biotechnologies, LLC.,
Lakewood, CO; TourniTek, Seattle, WA;
West Therapeutic Development, LLC.,
Northbrook, IL; Maryland Development
Center, Baltimore, MD; Tessonics
Medical Systems Inc., BIRMINGHAM,
MI; Vir Biotechnology, San Francisco,
CA; Wound Exam Corp., Beverly Hills,
CA; Creare LLC., Hanover, NH; Drexel
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 87, Number 9 (Thursday, January 13, 2022)]
[Notices]
[Page 2178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00581]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--The Integrated Photonics Institute for
Manufacturing Innovation Operating Under the Name of the American
Institute for Manufacturing Integrated Photonics
Notice is hereby given that, on November 23, 2021, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), the Integrated Photonics
Institute for Manufacturing Innovation operating under the name of the
American Institute for Manufacturing Integrated Photonics (``AIM
Photonics'') has filed written notifications simultaneously with the
Attorney General and the Federal Trade Commission disclosing changes in
its membership. The notifications were filed for the purpose of
extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Regents of the University of Minnesota, Minneapolis, MN;
Buhler Inc. Leybold Optics, Cary, NC; and Spark Photonics Design, Inc.,
Waltham, MA, have been added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and AIM Photonics intends to file
additional written notifications disclosing all changes in membership.
On June 16, 2016, AIM Photonics filed its original notification
pursuant to Section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to Section 6(b) of
the Act on July 25, 2016 (81 FR 48450).
The last notification was filed with the Department on August 19,
2021. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on October 5, 2021 (86 FR 55001).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-00581 Filed 1-12-22; 8:45 am]
BILLING CODE 4410-11-P
